PharmaTher Unveils KetaVault™: A First-of-Its-Kind Portal to Accelerate Ketamine Research and Commercialization
Article content
KetaVault™ to Provide Partners Unprecedented Access to PharmaTher's Extensive Regulatory, Manufacturing, and Clinical Ketamine Data, Aiming to Expedite New Therapies and Market Entry
Article content
Article content
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the 'Company' or 'PharmaTher') (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on the research and commercialization of ketamine for unmet medical needs, today announced the launch of KetaVault™. This innovative, world-first portal offers pharmaceutical and biotech companies, academic and clinical researchers, and government agencies to partner with PharmaTher for direct access to its comprehensive proprietary data on ketamine. KetaVault™ is strategically designed to streamline and accelerate clinical trials, regulatory submissions, and commercialization initiatives for ketamine-based therapies.
Article content
Article content
The launch of KetaVault™ is strategically timed with the Company's anticipated FDA approval for its ketamine product, which has an approval goal date of June 4, 2025. This dual milestone underscores PharmaTher's commitment to leading innovation in the ketamine space. KetaVault™ is positioned to be a pivotal catalyst, empowering partners to leverage PharmaTher's deep expertise and data to unlock new therapeutic avenues for ketamine in areas of high unmet medical need and for emergency use applications, potentially revolutionizing treatment paradigms.
Article content
Fabio Chianelli, Chairman and CEO of PharmaTher, commented:
'PharmaTher is committed to revolutionizing patient care through ketamine. With KetaVault™, PharmaTher isn't just sharing data; we're igniting a new era of collaborative ketamine innovation. This platform is a bold step toward unlocking the full potential of ketamine, empowering our partners with unprecedented access to our years of dedicated work, rich proprietary insights, and collectively accelerating the journey towards novel treatments for patients in critical need. As we near our FDA approval goal date for ketamine, KetaVault™ will serve as a critical tool to expand ketamine's therapeutic reach and solidify PharmaTher's leadership in the market for ketamine, creating significant value for our partners and shareholders.'
Article content
Article content
Expedited Regulatory Pathways: Leverage existing data to potentially streamline investigational new drug applications and emergency use authorizations.
De-risked Clinical Development: Inform trial design, safety and efficacy data, and identify promising indications based on robust existing research.
Enhanced Commercial Strategy: Gain insights into manufacturing, control, and product development for market readiness.
Article content
Regulatory Filings: Investigational New Drug (IND) Applications.
Comprehensive Drug Information: Investigator's Brochures.
Manufacturing Insights: Chemistry, Manufacturing, and Control (CMC) data.
Clinical Research & Data: In-depth clinical study protocols and research data for indications including Parkinson's disease.
Orphan Drug Designations: Access to information supporting FDA Orphan Drug Approvals for Amyotrophic Lateral Sclerosis, Rett Syndrome, Complex Regional Pain Syndrome, Status Epilepticus, and ischemia/reperfusion injury during solid organ transplantation.
Novel Delivery Systems: Product development programs and regulatory filings for PharmaTher's ketamine microneedle patch and subcutaneous wearable pump.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Sun
8 hours ago
- Toronto Sun
TERRAZZANO: Ottawa should be selling Canada Post and not bailing it out
Canada Post distribution centre Lléo Blanchette on Friday May 23, 2025. Canada Post averted a nation wide strike on Friday as union employees implemented work to rule pressure tactic. Photo by Pierre Obendrauf / Montreal Gazette Here's a bold prediction: Canada Post won't pay back a dime of the $1-billion bailout it's taking from taxpayers. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account The federal government gave Canada Post up to $1 billion in 'repayable funding' to 'prevent insolvency.' Canada Post is supposed to pay that funding back to taxpayers 'insofar as (Canada Post's) revenues are sufficient.' With Canada Post bleeding money, taxpayers shouldn't hold their breath waiting for that money to be paid back. Canada Post lost $841 million last year. It was the Crown corporation's seventh straight year losing money, with losses totalling $3.8 billion over those years. 'Canada Post is facing an existential crisis: It is effectively insolvent, or bankrupt,' according to the report of the Industrial Inquiry Commission. And as bad as the last few years were, Canada Post's financial situation could get worse. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. 'The funding does not solve the Corporation's structural issues,' Canada Post wrote. In its 2023 Annual Report, Canada Post warned of 'larger, unsustainable losses in future years.' The nature of taxpayer bailouts is that more bailouts soon follow. And Canada Post appears ready to go back to the government with cap in hand. '(Canada Post) welcomes the federal government's announcement of the repayable funding and may require additional short-term borrowing to remain solvent through 2025,' Canada Post said. 'In its current financial situation … (Canada Post) will need additional annual funding going forward to maintain operations and meet employee obligations.' There are three things any would-be champion of taxpayers in Ottawa should do with this situation. This advertisement has not loaded yet, but your article continues below. First, members of Parliament should oppose taxpayers bailing out Canada Post. If Canada Post is to exist, then it should be forced to operate like a business and stand on its own two feet. Second, MPs should hold Canada Post accountable to paying back every dime of the $1 billion it takes from taxpayers. If Canada Post doesn't pay every cent back, MPs should ask a simple question every day in the House of Commons: Who is getting fired? Third, and most importantly, MPs should push for the real solution: Sell Canada Post. The government should sell Canada Post and use the money to start paying down its $1-trillion debt like other countries. 'By selling (Royal Mail), we help that important national business to prosper and invest in the future, while we use the money we get to pay down the national debt and pay less interest on that debt as a result,' said George Osborne, then-United Kingdom chancellor of the exchequer when the country privatized its postal service. This advertisement has not loaded yet, but your article continues below. Other countries like Germany, Portugal, the Netherlands, Japan, Israel, Belgium, Malta and Austria sold or partially privatized their government postal company. In Europe, the delivery of all letters has been open to competition since 2013, effectively ending postal monopolies. 'Austria, the Netherlands and Germany privatized their state-owned mail services,' and 'in these countries, inflation-adjusted stamp prices fell between 11% and 17% within 10 years,' explains economist Vincent Geloso. Contrast that with the experience of Canada Post since it became a Crown corporation. 'Almost immediately, stamp prices increased steeply, from 17 cents to 30 cents, and since then, Canada Post has consistently increased prices faster than inflation (to $1.44 today),' according to Geloso. Canada Post is not worth its cost to taxpayers and consumers. Instead of bailing out the failing Crown corporation, MPs should push to sell Canada Post. Franco Terrazzano is federal director of the Canadian Taxpayers Federation Olympics Columnists World Editorial Cartoons NHL
Toronto Sun
21 hours ago
- Toronto Sun
Letters to the Editor, June 7, 2025
Saturday letters Photo by Illustration / Toronto Sun THE SPREAD OF AI This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account The article 'Artificial intelligence could spark massive job loss in U.S.: Expert' (Postmedia News, June 1) does not reflect my experience. The current AI trying to handle customer phone inquiries can better be described as 'Automated Idiots' not 'Artificial Intelligence.' Beyond telling me my current balance, I have yet to encounter one that could actually solve my issue without handing the call over to a human. If companies think today's AI is capable of replacing phone support, they will create a lot of dissatisfied customers. While having so many unhappy customers may ultimately result in massive job losses, it's probably not the business model they were hoping for. Steen I. Petersen Nanaimo, B.C. (The long term issue is the AI is going to improve by the week and will be able to handle some of these more complex issues) This advertisement has not loaded yet, but your article continues below. CHOW DOES NOT CARE Re 'Home wrecker' (Brian Lilley, June 4): Corporations only have so much money to donate to charities. The Home Depot could be moving the Pride donation to a more deserving charity, perhaps one that will save lives. But Olivia Chow does not care about those other charities. There is a lesson to be learned. If you are not going to donate to Pride forever, then why bother in the first place. Because when you decide to move the charitable donation, you risk damaging the reputation and profitability of your company when politicians like Chow call for a boycott. They should be thanking the Home Depot for all their years of support, wishing them well and hoping they will come back. What an ungrateful group of people led by Chow. Her comments make sure the Home Depot won't be coming back any time soon. Ross Devenport Uxbridge (Chow is a mess of a mayor enabled by councillors who share her view. Toronto needs change) FIRES RAGING As a Canadian citizen increasingly affected by worsening wildfire seasons — including the hazardous smoke that now routinely blankets our cities, I urge our government to re-examine national priorities through a lens of climate resilience and public health. Michel Pinard Ottawa (This should be achieved in conjunction with proper forest management) Olympics NHL Toronto & GTA Columnists Toronto & GTA
Cision Canada
a day ago
- Cision Canada
MTL Cannabis Corp. Announces Shareholder Alignment Initiative
PICKERING, ON, June 6, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") announced today its shareholder alignment initiatives through the implementation of a long-term incentive plan ("LTIP"). In connection with the approval of the LTIP, executive officers were granted restricted share units ("RSUs") and deferred share units ("DSUs"), with deferred vesting. This initiative reflects the Company's commitment to aligning the executive team interests with shareholders and to support retention and leadership stability. The grant was comprised of two million RSUs and three million DSUs, with the RSUs vesting annually in arrears over three years and the DSUs vesting on the third anniversary of the grant. About MTL Cannabis Corp. MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. ("MTL Cannabis"), a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis. It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services. For further information, please visit or the Company's public filings at Cautionary Statement Regarding Forward-Looking Information. This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
